ASGCT Annual Meeting 2023 – Los Angeles, California

Samira is the Director of Technical Program Design for Viral Vector Services at Thermo Fisher Scientific. Samira oversees Viral Vector program design team - providing technical knowledge and strategic support - enabling customers to achieve their clinical and commercial goals

Samira's career in the CDMO industry spans over ten years, with expertise focused on development and manufacturing of monoclonal antibodies, small molecules, and viral vectors. She has a strong background in process development and scale up, and is experienced with general regulatory requirements for gene therapies.

Betty currently serves as Vice President of Cell, Gene, and Advanced Therapies, spanning biosciences, bioproduction, and laboratory products businesses across Thermo Fisher Scientific, leveraging “total company” to address the needs of developers and manufacturers of cell and gene therapies. The business focuses on fit-for-purpose product solutions that in partnership with our customers, is increasing the accessibility of these life-changing cell and gene therapies to patients.

Prior to this role, she formed and led a corporate team focused on scientific collaborations with Thermo Fisher strategic customers, as Vice President, Enterprise Science & Innovation (2018-2020), and served as VP of Corporate Accounts with responsibility for cultivating executive relationships with global biopharma (2009-2017). Prior to her corporate roles, Betty served in leadership roles in Fisher Scientific, including Industry Vice President, Biotechnology (2004-2008);